Comparison of acute respiratory events between: Asthma-COPD overlap syndrome and COPD patients

Medicine (United States)

Volumn 94, Issue 17, 2015, Pages e755-

  Chung, Wei Sheng ^a,b,c   Lin, Cheng Li ^d,e   Kao, Chia Hung ^f,g  

^a Taichung Hospital   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Department of Healthcare Administration ^*  (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e Pediatric Dentistry   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ACUTE RESPIRATORY FAILURE; ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME; CARDIOPULMONARY ARREST; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; TAIWAN; COMPLICATION; HEART ARREST; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; SYNDROME;

ACUTE DISEASE; AGED; ASTHMA; COHORT STUDIES; HEART ARREST; HUMANS; INCIDENCE; MIDDLE AGED; PNEUMONIA; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; SYNDROME; TAIWAN;

EID: 84937511777     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000755     Document Type: Article

References (28)

1. De Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PloS One. 2013; 8: e62985.
2. Nakawah MO, Hawkins C, Barbandi F. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome. J Am Board Fam Med. 2013; 26: 470-477.
3. Soler-Cataluña JJ, Cosió B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012; 48: 331-337.
4. Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013; 6: 197-219.
5. McDonald VM, Simpson JL, Higgins I, et al. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age Ageing. 2011; 40: 42-49.
6. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003; 124: 474-481.
7. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma COPD Asthma-COPD Overlap Syndrome. Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2014. www.ginasthma.org. Accessed November 20, 2014.
8. Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000; 356: 1313-1317.
9. Hardin M, Silverman EK, Barr RG, et al., COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011; 12: 127.
10. Menezes AM, Montes de Oca M, Pérez-Padilla R, et al., PLATINO Team. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014; 145: 297-304.
11. Universal Health Coverage in Taiwan. National Health Insurance Administration, Ministry of Health and Welfare; 2014. http://www.nhi.gov.tw/english/index.aspx. Accessed November 10, 2014.
12. Shen TC, Chung WS, Lin CL, et al. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study. PloS One. 2014; 9: e98290.
13. Chung WS, Lin CL, Chen YF, et al. Increased stroke risk among adult asthmatic patients. Eur J Clin Invest. 2014; 44: 1025-1033.
14. Chung WS, Lin CL, Ho FM, et al. Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study. Eur Respir J. 2014; 43: 801-807.
15. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010; 7: 32-43.
16. Tálamo C, de Oca MM, Halbert R, et al., PLATINO Team. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007; 131: 60-67.
17. Menezes AM, Victora CG, Perez-Padilla R. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004; 4: 15.
18. Lai CK, Beasley R, Crane J, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009; 64: 476-483.
19. Patel SP, Jarvelin MR, Little MP. Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environ Health. 2008; 7: 57.
20. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000; 160: 1683-1689.
21. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011; 48: 279-285.
22. Gold DL, Dawson M, Yang H, et al. Clinical trial simulation to assist in COPD trial planning and design with a biomarker-based diagnostic: when to pull the trigger? COPD. 2014; 11: 226-235.
23. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162: 1773-1777.
24. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J. 2007; 29: 906-913.
25. Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013; 41: 1252-1256.
26. Miravitlles M, Calle M, Soler-Cataluna JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012; 48: 86-98.
27. Miravitlles M, Soler-Cataluña JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J. 2013; 22: 117-121.
28. Decramer M, Vestbo J, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention for Chronic Obstructive Pulmonary Disease; 2014. Accessed November 5, 2014.